Projekt

A Phase 3 Study Comparing Daratumumab, VELCADE (bortezomib), Lenalidomide, and Dexamethasone (D-VRd) vs VELCADE, Lenalidomide, and Dexamethasone (VRd) in Subjects with Previously Untreated Multiple Myeloma who are Eligible for High-dose Therapy

Laufend - Rekrutierung – beendet · 2019 bis 2025

Schittenhelm Marcus, Berbic Hong Phuong, Quinter Janine